Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 55, 1995 - Issue sup221
Submit an article Journal homepage
18
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Breast cancer and clinical utility of CA 15—3 and CEA

W. Jäger Department Obstetrics Gynecology, University of Erlangen-Nuremberg, Erlangen, Germany
,
S. Krämer Department Obstetrics Gynecology, University of Erlangen-Nuremberg, Erlangen, Germany
,
V. Palapelas Department Obstetrics Gynecology, University of Erlangen-Nuremberg, Erlangen, Germany
&
L. Norbert Department Obstetrics Gynecology, University of Erlangen-Nuremberg, Erlangen, Germany
Pages 87-92 | Published online: 08 Jul 2009

References

  • Jager W. The early detection of disseminated (metastasized) breast cancer by serial turnour marker measurements. Eur J Cancer Prevention 1994; 2: 133–139, suppl 3
  • Jager W, Kissing A, Cilaci S, Melsheimer R, Lang N. Is an increase in CA 125 in breast cancer patients an indicator of pleural metastases?. Br J Cancer 1994; 70: 493–495
  • Jager W, Cilaci S, Merkle E, Palapelas V, Lang N. Analysis of the first signs of metastases in breast cancer patients. Tumourdiagn u Ther 1991; 12: 60–64
  • Hughes L E, Courtney S P. Follow-up of patients with breast cancer. Br Med J 1985; 290: 1229–1230
  • Bonadonna G. From adjuvant to neo-adjuvant chemotherapy in high-risk breast cancer: The experience of the Milan Cancer Institute. Steiner award lecture. Int J Cancer 1993; 1992; 55: 1–4
  • Pizzichetta M, Bogni A, Seregni E, Maffioloi L, De Jager E, Costa A, Bombardieri E. CA 15—3 as a signal of undetectable breast cancer metastases in a follow-up period of 4 years. Int J Biol Markers 1992; 7: 59–60
  • Dnistrian A M, Schwarz M K, Greenberg E J, Smith C A, Schwartz D C. CA 15—3 and carcinoembryonic antigen in the clinical evaluation of breast cancer. Clin Chim Acta 1991; 200: 81–94
  • Coates A, Gebski M. Improving the quality of life during chemotherapy for advanced breast cancer. N Engl J Med 1987; 317: 1490–1495
  • Fisher B, Wickerham D L, Redmond C. Recent developments in the use of systemic adjuvant therapy for the treatment of breast cancer. Semin Oncol 1992; 19: 263–277
  • Torniak E, Piccart M. Routine follow-up of patients after primary therapy for early breast cancer: changing concepts and challenges for the future. Ann Oncol 1993; 4: 199–204

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.